financetom
Business
financetom
/
Business
/
Expect financial year 2023-24 margins at 25 percent, High end testing aiding revenue per patient: Dr. Lal PathLabs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Expect financial year 2023-24 margins at 25 percent, High end testing aiding revenue per patient: Dr. Lal PathLabs
May 12, 2023 2:42 AM

"Expect financial year 2023-24 margins at 25 percent" Om Manchanda, Dr. Lal PathLabs said in an interaction with CNBC-TV18 on Friday. The diagnostics and related healthcare tests provider declared its fourth quarter results on Thursday and the stock is trading 1 percent higher on the exchanges on Friday at 10:30 am.

Share Market Live

NSE

The company's consolidated net profit declined 7.5 percent to Rs 56.7 crore in the fourth quarter ended March 31, 2022 — much lower than CNBC-TV18's poll of Rs 65.7 crore. This is the sixth consecutive fall in quarterly profit as a continued slide in income from COVID-related testing outpaced growth in its core business. Revenue from operations, however, rose to Rs 491 crore in the fourth quarter as against Rs 485.5 crore in the year-ago period, Dr Lal Pathlabs said in a statement.

Dr. Lal PathLabs is the first among its peers to report results and will set the tone for an intensely competitive industry that made large gains during the pandemic.

Dr. Lal PathLabs management while interacting with CNBC-TV18 on Friday added that the competitive intensity has reduced and witnessed a flat pattern between third and fourth quarters of 2022-23 for non-COVID revenue.

Manchanda further says that revenue per patient has been aided by bundled packages and mix changes. "The high end testing has aided the revenue per patient ratio for the company". It is also confident of sustaining growth seen in the past, while volume growth is expected at 8 to 9 percent.

The company further adds that screening packages are gaining ground. It recently launched a reference lab In Mumbai. The diagnostics and related healthcare tests provider expects to clock 25 percent margins in FY compared with 23.5 clocked in fourth quarter of financial year 2022-23.

In the recently hosted conference call for analysts, the company said its gross margins expanded 190bps year on year due to a change in test mix and price hikes taken in February 2023. Furthermore, specialized tests have scaled up significantly and are expanding to newer geographies including tier 2-3 towns. The industry growth is normalizing to 10 to 11 percent and the quality of assets available for inorganic growth has declined.

(Edited by : Vahishta Unwalla)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AT&T beats estimates for subscriber additions on demand for higher-priced plans
AT&T beats estimates for subscriber additions on demand for higher-priced plans
Jul 24, 2024
(Reuters) -AT&T ( T ) exceeded market expectations for wireless subscriber additions in the second quarter on Wednesday, as the telecom operator's higher-tier unlimited plans attracted customers. Shares of the company rose 2.4% in premarket trading. The company added 419,000 monthly bill-paying wireless phone subscribers, compared with expectations of 284,800 additions, according to five analysts polled by FactSet. AT&T's (...
US closes probe into 1.5 mln Honda vehicles over loss of power
US closes probe into 1.5 mln Honda vehicles over loss of power
Jul 24, 2024
July 24 (Reuters) - The U.S. National Highway Traffic Safety Administration said on Wednesday it has closed a preliminary evaluation investigation of about 1.5 million Honda ( HMC ) vehicles over loss of power. In November 2022, NHTSA's Office of Defects Investigation (ODI) had opened an investigation for 2018 to 2022 model year Honda CR-V and HR-V vehicles equipped with...
Patriot Battery Metals Files Final Base Shelf Prospectus
Patriot Battery Metals Files Final Base Shelf Prospectus
Jul 24, 2024
06:32 AM EDT, 07/24/2024 (MT Newswires) -- Patriot Battery Metals ( PMETF ) late on Tuesday said it has obtained a receipt for a final short form base shelf prospectus. The base shelf prospectus will allow the company to offer and issue common shares, debt, warrants and other securities for up to an offering price of $250 million during the...
Thermo Fisher Scientific's Fiscal Q2 Adjusted Earnings Rise, Revenue Drops; Raises Fiscal 2024 Outlook
Thermo Fisher Scientific's Fiscal Q2 Adjusted Earnings Rise, Revenue Drops; Raises Fiscal 2024 Outlook
Jul 24, 2024
06:31 AM EDT, 07/24/2024 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported fiscal Q2 adjusted earnings Wednesday of $5.37 per share, up from $ 5.15 a year earlier. Analysts polled by Capital IQ expected $5.13. Revenue for the quarter ended June 29 was $10.54 billion, down from $10.69 billion a year earlier. Analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved